MRVI vs. ARES
Compare and contrast key facts about Maravai LifeSciences Holdings, Inc. (MRVI) and Ares Management Corporation (ARES).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MRVI or ARES.
Correlation
The correlation between MRVI and ARES is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
MRVI vs. ARES - Performance Comparison
Key characteristics
MRVI:
-0.26
ARES:
1.33
MRVI:
0.28
ARES:
1.82
MRVI:
1.04
ARES:
1.23
MRVI:
-0.27
ARES:
2.88
MRVI:
-0.75
ARES:
7.95
MRVI:
34.34%
ARES:
4.59%
MRVI:
100.09%
ARES:
27.55%
MRVI:
-93.48%
ARES:
-45.85%
MRVI:
-93.48%
ARES:
-9.35%
Fundamentals
MRVI:
$1.03B
ARES:
$58.46B
MRVI:
-$1.67
ARES:
$2.04
MRVI:
$202.78M
ARES:
$2.69B
MRVI:
$82.48M
ARES:
$1.51B
MRVI:
-$136.20M
ARES:
$1.61B
Returns By Period
In the year-to-date period, MRVI achieves a -27.52% return, which is significantly lower than ARES's 1.50% return.
MRVI
-27.52%
-24.47%
-55.42%
-24.90%
N/A
N/A
ARES
1.50%
-7.72%
26.66%
40.02%
39.71%
30.53%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
MRVI vs. ARES — Risk-Adjusted Performance Rank
MRVI
ARES
MRVI vs. ARES - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Maravai LifeSciences Holdings, Inc. (MRVI) and Ares Management Corporation (ARES). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
MRVI vs. ARES - Dividend Comparison
MRVI has not paid dividends to shareholders, while ARES's dividend yield for the trailing twelve months is around 2.07%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MRVI Maravai LifeSciences Holdings, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ARES Ares Management Corporation | 2.07% | 2.10% | 2.59% | 3.57% | 2.31% | 3.40% | 3.59% | 7.50% | 6.30% | 4.32% | 6.81% | 2.45% |
Drawdowns
MRVI vs. ARES - Drawdown Comparison
The maximum MRVI drawdown since its inception was -93.48%, which is greater than ARES's maximum drawdown of -45.85%. Use the drawdown chart below to compare losses from any high point for MRVI and ARES. For additional features, visit the drawdowns tool.
Volatility
MRVI vs. ARES - Volatility Comparison
Maravai LifeSciences Holdings, Inc. (MRVI) has a higher volatility of 16.06% compared to Ares Management Corporation (ARES) at 7.85%. This indicates that MRVI's price experiences larger fluctuations and is considered to be riskier than ARES based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
MRVI vs. ARES - Financials Comparison
This section allows you to compare key financial metrics between Maravai LifeSciences Holdings, Inc. and Ares Management Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities